The company, which traces its roots back to 1886, will break into two: One company will focus on consumer health products customers can buy over the counter, including Benadryl, Band-Aids and Tylenol. The other business will sell prescription drugs and medical devices. Both will be publicly traded companies.
The separation is aimed at creating “two global leaders that are better positioned to deliver improved health outcomes for patients and consumers through innovation,” the company said in a statement. Leadership and the new name of the consumer-focused division haven’t yet been…
